Quantum Biopharma’s subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Where Today's News Shapes Tomorrow
